Overview
No overview information available.
Background
No background information available.
Indication
适用于9岁～45岁的女性，预防HPV16型、18型、31型、33型、45型、52型和58型引起的宫颈癌、外阴癌、阴道癌和肛门癌，以及HPV6型和11型型引起的生殖器疣。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58）Vaccine | 国药准字SJ20215001 | 生物制品 | 注射剂 | 1/5/2024 | |
| Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58）Vaccine | 国药准字SJ20180008 | 生物制品 | 注射剂 | 1/5/2024 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||